Oncternal Therapeutics Price on April 5, 2024

ONCTDelisted Stock  USD 0.53  0.00  0.00%   
If you're considering investing in Oncternal Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncternal Therapeutics stands at 0.53, as last reported on the 16th of December 2024, with the highest price reaching 0.53 and the lowest price hitting 0.53 during the day. Oncternal Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Oncternal Therapeutics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncternal Therapeutics' Coefficient Of Variation of (588.70), variance of 154.07, and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide.
  
Oncternal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1126

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsONCT

Estimated Market Risk

 10.87
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.22
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Oncternal Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncternal Therapeutics by adding Oncternal Therapeutics to a well-diversified portfolio.

Oncternal Therapeutics Valuation on April 5, 2024

It is possible to determine the worth of Oncternal Therapeutics on a given historical date. On April 5, 2024 Oncternal was worth 8.81 at the beginning of the trading date compared to the closed value of 8.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oncternal Therapeutics stock. Still, in general, we apply an absolute valuation method to find Oncternal Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oncternal Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oncternal Therapeutics' related companies.
 Open High Low Close Volume
  9.26    9.26    8.49    8.80    9,784  
04/05/2024
  8.81    8.81    8.32    8.65    9,343  
  8.76    9.00    8.65    9.00    5,591  
Backtest Oncternal Therapeutics  |  Oncternal Therapeutics History  |  Oncternal Therapeutics Valuation   PreviousNext  
Open Value
8.81
8.65
Closing Value
41.43
Upside

Oncternal Therapeutics Trading Date Momentum on April 5, 2024

On April 08 2024 Oncternal Therapeutics was traded for  9.00  at the closing time. The top price for the day was 9.00  and the lowest listed price was  8.65 . The trading volume for the day was 5.6 K. The trading history from April 8, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 4.05% . The trading delta at closing time against the current closing price is 8.09% .

Oncternal Therapeutics Fundamentals Correlations and Trends

By evaluating Oncternal Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oncternal Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oncternal financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oncternal Therapeutics Stock history

Oncternal Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncternal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncternal Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncternal Therapeutics stock prices may prove useful in developing a viable investing in Oncternal Therapeutics
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. Oncternal Therapeutics, Inc. has a research collaboration with Celularity Inc. to evaluate placental derived-cellular therapies targeting ROR1. Oncternal Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Oncternal Therapeutics Stock Technical Analysis

Oncternal Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Oncternal Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oncternal Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oncternal Therapeutics Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oncternal Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oncternal Therapeutics December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Oncternal Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncternal Therapeutics shares will generate the highest return on investment. By undertsting and applying Oncternal Therapeutics stock market strength indicators, traders can identify Oncternal Therapeutics entry and exit signals to maximize returns

Oncternal Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oncternal Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Oncternal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncternal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Oncternal Stock

If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules